NYSE · MMS
Industrials · Specialty Business Services
$55.65
Up+$0.97 (+1.77%)
Updated Oct 8, 2026, 4:10 AM
SID Score
4.2/10
Composite research score
Smart Money
58/100
Neutral
Price performance · MMS
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 7, 2026
MMS closed at $55.65 after 21 trading sessions, down 0.82% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 7, 2026 | $54.69 | $56.04 | $54.04 | $55.65 | 869.47K |
| Oct 6, 2026 | $54.55 | $54.92 | $53.80 | $54.68 | 666.15K |
| Oct 5, 2026 | $52.55 | $54.45 | $52.45 | $54.41 | 731.51K |
| Oct 2, 2026 | $53.69 | $53.69 | $52.61 | $52.65 | 610.06K |
| Oct 1, 2026 | $54.23 | $55.495 | $53.52 | $53.53 | 1.07M |
| Sep 30, 2026 | $53.20 | $53.65 | $52.79 | $53.19 | 836.1K |
| Sep 29, 2026 | $51.86 | $53.10 | $51.17 | $53.07 | 896.88K |
| Sep 28, 2026 | $51.90 | $52.46 | $51.036 | $52.10 | 1.01M |
| Sep 25, 2026 | $52.17 | $53.355 | $51.68 | $52.61 | 504.22K |
| Sep 24, 2026 | $53.90 | $54.32 | $52.025 | $52.62 | 695.2K |
| Sep 23, 2026 | $56.05 | $56.05 | $53.65 | $53.79 | 536.89K |
| Sep 22, 2026 | $56.79 | $56.79 | $55.18 | $55.18 | 698.78K |
| Sep 21, 2026 | $55.96 | $56.72 | $55.716 | $55.97 | 700K |
| Sep 18, 2026 | $56.39 | $56.715 | $55.65 | $55.94 | 1.95M |
| Sep 17, 2026 | $57.65 | $57.68 | $56.69 | $56.81 | 611.53K |
| Sep 16, 2026 | $57.93 | $58.79 | $57.425 | $57.61 | 678.63K |
| Sep 15, 2026 | $58.46 | $59.10 | $57.86 | $58.18 | 754.75K |
| Sep 14, 2026 | $58.52 | $59.79 | $57.155 | $59.35 | 816.51K |
| Sep 11, 2026 | $56.67 | $57.42 | $55.965 | $56.92 | 453.67K |
| Sep 10, 2026 | $56.04 | $57.025 | $55.88 | $56.53 | 447.53K |
| Sep 9, 2026 | $56.42 | $56.66 | $55.34 | $56.11 | 824.69K |
The latest Smart Investors Daily articles mentioning MMS.
Company
Market Activity
Research & News
MMS research
Company profile and research snapshot.
Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jan 2, 2025 | Raymond James | Outperform | — |
| Jan 3, 2024 | Raymond James | Market Perform | — |
| Aug 18, 2023 | Stifel | Buy | — |
| Feb 9, 2023 | Raymond James | Outperform | — |
| May 6, 2022 | Raymond James | Outperform | — |
No generated briefing is available yet.
SeekingAlpha · Sep 24, 2026
Even if the paused VA incentives never come back, Maximus trades at about 8x earnings, below every government services peer. Learn more about MMS stock here.
Yahoo · Sep 22, 2026
Third Avenue Management, an investment management company, released its second-quarter 2026 investor letter for the “Third Avenue Small-Cap Value Fund”. You can download the letter here. The Third Avenue Small-Cap Value Fund returned 12.85% in Q2 2026, outperforming the MSCI USA Small Cap Value Index (12.61%) but underperforming the Russell 2000 Value Index (17.19%). Year-to-date, […]
ChartMill · Sep 19, 2026
MAXIMUS (MMS) screens cheap at 7x earnings with strong ROE and cash flow. See how it fits the Decent Value strategy and avoids value traps.
ChartMill · Sep 14, 2026
MAXIMUS (MMS) screens as a quality stock with strong ROIC, cash conversion, and cheap valuation, though modest revenue growth remains a key risk.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning MMS.
